Home
Anson Funds Management reported a 9.9% stake in Transcode Therapeutics RNAZ · 113,479 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 9.9%
- Last report
- First report
- Shares held
- 113,479 sh
- Class
- Common Stock, $0.0001 par value
- Holder
- Anson Funds Management
- Event date
- 24/12/31
- Filed
- 25/02/14
First 5%+ report · 9.9% stake
Transcode Therapeutics trades, last 26 weeks
What else happened in Transcode Therapeutics around then
Filed or reported within 30 days of the trade day · 24/12/01~25/01/30Anson Funds Management's other 5% stake reports
- Anson Funds Management
5% stake22nd Century Group
5% stake22nd Century Group
XXII
6.7% stake
34,565 sh
6.7% stake
Filed 08/14
- Anson Funds Management
5% stakeNexus Advanced Technologies
5% stakeNexus Advanced Technologies
NXAT
1.3% stake
805,795 sh
1.3% stake
Filed 08/14
- Anson Funds Management
5% stakeVenu Holding
5% stakeVenu Holding
VENU
8.4% stake
4,996,578 sh
8.4% stake
Filed 08/14
- Anson Funds Management
5% stakeSealsq
5% stakeSealsq
LAES
4.9% stake
10,059,050 sh
4.9% stake
Filed 08/14
- Anson Funds Management
5% stakeSono Group
5% stakeSono Group
SSM
9.9% stake
142,000 sh
9.9% stake
Filed 08/14
